Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective: Treatment of early-onset schizophrenia spectrum psychosis (EOS) is hampered by limited data on clinical presentation and illness course. We aimed to systematically review the clinical characteristics, diagnostic trajectories, and predictors of illness severity and outcomes of EOS. Methods: We conducted a systematic PubMed, PsycINFO, and Embase literature review including studies published from January 1, 1990 to August 8, 2014 of EOS patients with 1) ≥50% nonaffective psychosis cases; 2) mean age of subjects <19 years; 3) clinical samples recruited through mental health services; 4) cross-sectional or prospective design; 5) ≥20 participants at baseline; 6) standardized/validated diagnostic instruments; and 7) quantitative psychotic symptom frequency or severity data. Exploratory analyses assessed associations among relevant clinical variables. Results: Across 35 studies covering 28 independent samples ( n = 1506, age = 15.6 years, age at illness onset = 14.5 years, males = 62.3%, schizophrenia-spectrum disorders = 89.0%), the most frequent psychotic symptoms were auditory hallucinations (81.9%), delusions (77.5%; mainly persecutory [48.5%], referential [35.1%], and grandiose [25.5%]), thought disorder (65.5%), bizarre/disorganized behavior (52.8%), and flat or blunted affect/negative symptoms (52.3%/50.4%). Mean baseline Positive and Negative Syndrome Scale (PANSS)-total, positive, and negative symptom scores were 84.5 ± 10.9, 19.3 ± 4.4 and 20.8 ± 2.9. Mean baseline Clinical Global Impressions-Severity and Children's Global Assessment Scale/Global Assessment of Functioning (CGAS/GAF) scores were 5.0 ± 0.7 and 35.5 ± 9.1. Comorbidity was frequent, particularly posttraumatic stress disorder (34.3%), attention-deficit/hyperactivity and/or disruptive behavior disorders (33.5%), and substance abuse/dependence (32.0%). Longer duration of untreated psychosis (DUP) predicted less CGAS/GAF improvement ( p < 0.0001), and poor premorbid adjustment and a diagnosis of schizophrenia predicted less PANSS negative symptom improvement ( p = 0.0048) at follow-up. Five studies directly comparing early-onset with adult-onset psychosis found longer DUP in EOP samples (18.7 ± 6.2 vs. 5.4 ± 3.1 months, p = 0.0027). Conclusions: EOS patients suffer substantial impairment from significant levels of positive and negative symptoms. Although symptoms and functioning improve significantly over time, pre-/and comorbid conditions are frequent, and longer DUP and poorer premorbid adjustment is associated with poorer illness outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716 · cited 2×
“1987) total score, and positive and negative symptom subscores; Clinical Global Impressions-Severity (CGI-S) scale (Guy 1976) scores; Children’s Global Assessment Scale (CGAS) (Shaffer et al. 1983); and Global Assessment of Functioning (GAF) (Endicott et al.”
Varese, F., Smeets, F., Drukker, M., Lieverse, R., Lataster, T., Viechtbauer, W., Read, J., van Os, J., & Bentall, R. P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs050 · Cited by 2,436 · cited 2×
“%) in the pooled samples supports the notion that trauma plays a role in the pathogenesis of EOS as well as in individuals with psychotic symptoms (Harley et al. 2010; Varese et al. 2012; Dvir et al. 2013; Aas et al. 2014; Daglas et al. 2014; Li et al. 2014).”
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias, G., & Remington, G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn094 · Cited by 594 · cited 4×
“These findings are consistent with results from adult studies (Fenton and McGlashan 1991; Foussias and Remington 2010; Moller et al. 2010; Carbon and Correll 2014), and with the results from a recent review showing that premorbid difficulties, greater symptom severity (especially negative symptoms) at baseline, a diag…”
Influentialvan den Berg, D. P. G., de Bont, P. A. J. M., van der Vleugel, B. M., de Roos, C., de Jongh, A., Van Minnen, A., & van der Gaag, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2637 · Cited by 341 · cited 1×
“The documentation of high rates of PTSD in EOS patients has important clinical implications, especially in the light of new evidence that standard protocols for PTSD treatment are effective, safe, and feasible in patients with psychotic disorders (van den Berg et al. 2015).”
Clinical predictors of therapeutic response to antipsychotics in schizophrenia
Carbon, M., & Correll, C. U. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mcarbon · Cited by 257 · cited 4×
“These findings are consistent with results from adult studies (Fenton and McGlashan 1991; Foussias and Remington 2010; Moller et al. 2010; Carbon and Correll 2014), and with the results from a recent review showing that premorbid difficulties, greater symptom severity (especially negative symptoms) at baseline, a diag…”
InfluentialSelf-citationHarley, M., Kelleher, I., Clarke, M., Lynch, F., Arseneault, L., Connor, D., Fitzpatrick, C., & Cannon, M. (2010) · Psychological Medicine · doi:10.1017/s0033291709991966 · Cited by 206 · cited 2×
“%) in the pooled samples supports the notion that trauma plays a role in the pathogenesis of EOS as well as in individuals with psychotic symptoms (Harley et al. 2010; Varese et al. 2012; Dvir et al. 2013; Aas et al. 2014; Daglas et al. 2014; Li et al. 2014).”
Salvatore, P., Baldessarini, R. J., Tohen, M., Khalsa, H.-M. K., Sanchez-Toledo, J. P., Zarate, C. A., Vieta, E., & Maggini, C. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04227 · Cited by 155
Arango, C., Fraguas, D., & Parellada, M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt198 · Cited by 119 · cited 1×
“Schizophrenia and bipolar disorders share both some clinical features and risk factors, and evidence suggests that the neurodevelopmental trajectories differ on a quantitative rather than a qualitative level (Arango et al. 2014).”
Jeppesen, P., Clemmensen, L., Munkholm, A., Rimvall, M. K., Rask, C. U., Jørgensen, T., Larsen, J. T., Petersen, L., van Os, J., & Skovgaard, A. M. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12319 · Cited by 84 · cited 1×
“Further, on the other end of the psychosis continuum, an estimated median of 10–17% of the general population of children and adolescents report nonclinically relevant psychotic symptoms, such as hallucinations and delusions (Kelleher et al. 2012; Jeppesen et al. 2015).”
Self-citation
Cited by
Adolescent Neurodevelopment and Vulnerability to Psychosis
Patel, P. K., Leathem, L. D., Currin, D. L., & Karlsgodt, K. H. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.028 · Cited by 152
Effects of age and sex on clinical high-risk for psychosis in the community
Schultze-Lutter, F., Schimmelmann, B. G., Flückiger, R., & Michel, C. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i5.101 · Cited by 34
Smelror, R. E., Bless, J. J., Hugdahl, K., & Agartz, I. (2019) · JMIR Formative Research · doi:10.2196/13882 · Cited by 25
Metadata
- Authors
- Stentebjerg-Olesen, M., Pagsberg, A. K., Fink-Jensen, A., Correll, C. U., & Jeppesen, P.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2016-06
- Volume
- 26
- Issue
- 5
- Pages
- 410-427
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2345610434
- Cited by
- 147
- References
- 11
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.